USRDS Coordinating Center
914 South 8th Street
Suite S-206
Minneapolis, MN 55404
(612) 347-7776
1-888-99USRDS
2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
2003

2003 ADR/Atlas
The 2003 Annual Data Report presents data on end-stage renal disease in the United States. The first section of the book, the atlas, focuses on a visual display of information through graphs and maps. You can view and download both PDF files of these chapters and Excel files of the data underlying the figures.  Slides of all the Atlas graphics. 

2003 ADR/Reference Tables
The reference tables in the second half of the ADR are similar to those of previous editions. Titles have been further clarified, and footnotes provide more information on the patient populations used in the analyses. You can view and download both PDF and Excel files of these tables. 

2003 ADR/Reference Tables (Medicare Only) 
These tables are a sub-set of the ADR/Reference Tables section.  The tables include patients who are Medicare Entitled as determined by the CMS EDB (Enrollment Data Base) system.  

Quotations used in the USRDS Annual Data Report

Click here for information to order the printed ADR and CD.

Suggested citation for this report:
Suggested citation for this report: U.S. Renal Data System, USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States,National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2003.

Publications based upon USRDS data reported here or supplied upon request must include this citation and the following notice: The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. government.

 

 
 

 

 

 

 
Quick Links
 
   
INTRODUCTION
PRÉCIS
HEALTHY PEOPLE 2010
CHRONIC KIDNEY DISEASE
INCIDENCE & PREVALENCE
PATIENT CHARACTERISTICS
TREATMENT MODALITIES
CLINICAL INDICATORS
OUTCOMES: HOSPITALIZATION & MORTALITY
TRANSPLANTATION
PEDIATRIC ESRD
CARDIOVASCULAR
REHABILITATION
ECONOMIC COSTS
INTERNATIONAL
APPENDICES
Reference Tables
A.  Incidence
B.  Prevalence
C.  Patients Char
D.  Treatment
E.  Morbidity & Hosp
F.  TX:  Process
G.  TX:  Outcomes
H.  Mortality
 I.  Patient Survival
J.  Provider Char
K.  Economic Costs 
L.  Census Populations